Log in

Neogen Stock Price, Forecast & Analysis (NASDAQ:NEOG)

$64.35
+0.03 (+0.05 %)
(As of 11/15/2019 08:00 AM ET)
Today's Range
$63.79
Now: $64.35
$64.86
50-Day Range
$62.61
MA: $65.04
$67.60
52-Week Range
$50.60
Now: $64.35
$79.83
Volume88,400 shs
Average Volume141,386 shs
Market Capitalization$3.37 billion
P/E Ratio55.96
Dividend YieldN/A
Beta1.37
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. Read More…

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:NEOG
CUSIP64049110
Phone517-372-9200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$414.19 million
Cash Flow$1.50 per share
Book Value$12.24 per share

Profitability

Net Income$60.18 million

Miscellaneous

Employees1,682
Market Cap$3.37 billion
Next Earnings Date12/19/2019 (Estimated)
OptionableOptionable

Receive NEOG News and Ratings via Email

Sign-up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter.


Neogen (NASDAQ:NEOG) Frequently Asked Questions

What is Neogen's stock symbol?

Neogen trades on the NASDAQ under the ticker symbol "NEOG."

When did Neogen's stock split? How did Neogen's stock split work?

Neogen's stock split before market open on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly created shares were payable to shareholders after the closing bell on Friday, December 29th 2017. An investor that had 100 shares of Neogen stock prior to the split would have 133 shares after the split.

How will Neogen's stock buyback program work?

Neogen announced that its Board of Directors has initiated a share repurchase plan on Wednesday, October 10th 2018, which authorizes the company to buyback 3,000,000 outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Shares buyback plans are often an indication that the company's board believes its shares are undervalued.

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) issued its quarterly earnings results on Tuesday, September, 24th. The company reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.29 by $0.01. The business had revenue of $101.42 million for the quarter, compared to analyst estimates of $105.16 million. Neogen had a return on equity of 9.46% and a net margin of 14.32%. The firm's quarterly revenue was up 1.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.29 earnings per share. View Neogen's Earnings History.

When is Neogen's next earnings date?

Neogen is scheduled to release their next quarterly earnings announcement on Thursday, December 19th 2019. View Earnings Estimates for Neogen.

What price target have analysts set for NEOG?

3 brokers have issued twelve-month price targets for Neogen's shares. Their forecasts range from $78.00 to $78.00. On average, they expect Neogen's stock price to reach $78.00 in the next twelve months. This suggests a possible upside of 21.2% from the stock's current price. View Analyst Price Targets for Neogen.

What is the consensus analysts' recommendation for Neogen?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neogen in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Neogen.

Has Neogen been receiving favorable news coverage?

Headlines about NEOG stock have been trending somewhat negative on Friday, according to InfoTrie. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Neogen earned a media sentiment score of -1.4 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Neogen.

Are investors shorting Neogen?

Neogen saw a decline in short interest during the month of October. As of October 15th, there was short interest totalling 2,930,000 shares, a decline of 9.0% from the September 15th total of 3,220,000 shares. Based on an average daily volume of 216,900 shares, the days-to-cover ratio is presently 13.5 days. Currently, 5.7% of the company's stock are short sold. View Neogen's Current Options Chain.

Who are some of Neogen's key competitors?

What other stocks do shareholders of Neogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neogen investors own include WP Carey (WPC), JPMorgan Chase & Co. (JPM), GW Pharmaceuticals PLC- (GWPH), NVIDIA (NVDA), Boeing (BA), Edwards Lifesciences (EW), Nike (NKE), Pfizer (PFE), AT&T (T) and Celgene (CELG).

Who are Neogen's key executives?

Neogen's management team includes the folowing people:
  • Mr. James L. Herbert, Exec. Chairman (Age 79)
  • Mr. John Edward Adent, CEO & Pres (Age 51)
  • Mr. Steven J. Quinlan, VP, CFO & Sec. (Age 57)
  • Ms. Terri A. Morrical, VP of Animal Safety Operations (Age 54)
  • Mr. Rod Poland, Director of Corp. Communications

Who are Neogen's major shareholders?

Neogen's stock is owned by a number of of retail and institutional investors. Top institutional investors include Conestoga Capital Advisors LLC (3.01%), Riverbridge Partners LLC (2.40%), Stephens Investment Management Group LLC (1.09%), North Point Portfolio Managers Corp OH (0.31%), Rhumbline Advisers (0.30%) and Teton Advisors Inc. (0.29%). Company insiders that own Neogen stock include Edward Bradley, G Bruce Papesh, Jack C Parnell, James L Herbert, James P Tobin, John Edward Adent, Steven J Quinlan, Terri A Morrical, Thomas H Reed and William T Boehm. View Institutional Ownership Trends for Neogen.

Which institutional investors are selling Neogen stock?

NEOG stock was sold by a variety of institutional investors in the last quarter, including Stephens Investment Management Group LLC, SG Americas Securities LLC, Conestoga Capital Advisors LLC, Teton Advisors Inc., Private Trust Co. NA, North Point Portfolio Managers Corp OH, Howe & Rusling Inc. and LS Investment Advisors LLC. Company insiders that have sold Neogen company stock in the last year include Jack C Parnell, James L Herbert, John Edward Adent, Steven J Quinlan, Terri A Morrical and William T Boehm. View Insider Buying and Selling for Neogen.

Which institutional investors are buying Neogen stock?

NEOG stock was purchased by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, California Public Employees Retirement System, State of Alaska Department of Revenue, Comerica Bank, Russell Investments Group Ltd., Beacon Investment Advisory Services Inc., Strs Ohio and Bridge City Capital LLC. Company insiders that have bought Neogen stock in the last two years include James P Tobin and John Edward Adent. View Insider Buying and Selling for Neogen.

How do I buy shares of Neogen?

Shares of NEOG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Neogen's stock price today?

One share of NEOG stock can currently be purchased for approximately $64.35.

How big of a company is Neogen?

Neogen has a market capitalization of $3.37 billion and generates $414.19 million in revenue each year. The company earns $60.18 million in net income (profit) each year or $1.15 on an earnings per share basis. Neogen employs 1,682 workers across the globe.View Additional Information About Neogen.

What is Neogen's official website?

The official website for Neogen is http://www.neogen.com/.

How can I contact Neogen?

Neogen's mailing address is 620 LESHER PLACE, LANSING MI, 48912. The company can be reached via phone at 517-372-9200 or via email at [email protected]


MarketBeat Community Rating for Neogen (NASDAQ NEOG)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  292 (Vote Outperform)
Underperform Votes:  399 (Vote Underperform)
Total Votes:  691
MarketBeat's community ratings are surveys of what our community members think about Neogen and other stocks. Vote "Outperform" if you believe NEOG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NEOG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel